EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Post‐ TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement

Marlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, Theresa Müllner-Bucsics, Susanna Riegler, Lukas Reider, Mathias Jachs iD, Lorenz Balcar iD, Eva M Schleicher, Jasmin Söhngen, Lukas Müller, Michael B Pitton und 8 weitere

Liver International · 2026

DOI: 10.1111/liv.70736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Marlene Hintersteininger und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: von Willebrand Factor, Portasystemic Shunt, Transjugular Intrahepatic, Hypertension, Portal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ludwig Boltzmann Gesellschaft, Dr. Rolf M. Schwiete Stiftung, Österreichische Gesellschaft für Gastroenterologie und Hepatologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Transjugular intrahepatic portosystemic shunt (TIPS) placement is used to treat complications of portal hypertension. This study aimed to evaluate the prognostic value of von Willebrand factor antigen (VWF) dynamics following TIPS placement.

Methods

Patients with TIPS placement at the Medical University of Vienna (2018–2025) and University Medical Center Mainz (2022–2025) with available VWF at baseline (BL) were included. Patients from both cohorts with available VWF after 3 months (M3) were included in the combined longitudinal cohort (CLC). Meaningful VWF decrease (VWF‐Response) was defined as a relative VWF change (ΔVWF) of at least −5% at M3. Patients were stratified by presence of VWF‐Response and interleukin‐6 decrease (IL6‐Response) into three groups: both (R2), either/or (R1), and neither (R0).

Results

Overall, 113 and 86 patients were included in the Vienna and Mainz cohorts, respectively. BL VWF was not associated with mortality in both cohorts. 118 patients constituted the CLC, which showed median BL VWF of 313.0% that decreased to 262.0% at M3 ( p = 0.007). Fifty‐three patients (44.9%) achieved VWF‐Response. Both, VWF change (ΔVWF; asHR: 2.75; 95% CI: 1.07–7.11; p = 0.037) and VWF‐Response (asHR: 0.24; 95% CI: 0.09–0.61; p = 0.003) were independently associated with survival. According to VWF and IL6 responses, patients were stratified as low‐risk (R2), versus intermediate‐risk (R1) versus high‐risk (R0) with a cumulative incidence of death at 2 years of follow‐up of R2: 10.6% versus R1: 23.1% versus R0: 46.7%, respectively.

Conclusion

After TIPS placement, VWF‐Response identifies patients with a favourable prognosis and can be combined with IL6‐Response for risk stratification regarding mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand FactorPortasystemic Shunt, Transjugular IntrahepaticHypertension, PortalHumansFemaleRisk AssessmentInterleukin-6MaleMiddle AgedPrognosisAdultLongitudinal StudiesAustria

Substanzen

von Willebrand FactorInterleukin-6

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Clinical Research Group MOTION, Medical University of Vienna, Vienna, Austria.
  • Department of Internal Medicine 1, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • Division of Cardiovascular and Interventional Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Department of Radiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.

ORCID-Profile: Mathias Jachs, Lorenz Balcar, Mattias Mandorfer, Thomas Reiberger, Christian Labenz, Lukas Hartl

Förderung

  • Ludwig Boltzmann Gesellschaft
  • Dr. Rolf M. Schwiete Stiftung
  • Österreichische Gesellschaft für Gastroenterologie und Hepatologie

Zitieren

APA

Hintersteininger, M., Gairing, S. J., Kirsch, K., Müllner-Bucsics, T., Riegler, S., Reider, L., Jachs, M., Balcar, L., Schleicher, E. M., Söhngen, J., Müller, L., Pitton, M. B., Weinmann-Menke, J., Lange, C. M., Galle, P. R., Trauner, M., Mandorfer, M., Reiberger, T., Labenz, C., & Hartl, L. (2026). Post‐ TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement. Liver International. https://doi.org/10.1111/liv.70736

Vancouver

Hintersteininger M, Gairing SJ, Kirsch K, Müllner-Bucsics T, Riegler S, Reider L, et al. Post‐ TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement. Liver International. 2026. doi:10.1111/liv.70736

BibTeX
@article{Hintersteininger2026,
  author = {Hintersteininger, Marlene and Gairing, Simon Johannes and Kirsch, Katrin and Müllner-Bucsics, Theresa and Riegler, Susanna and Reider, Lukas and Jachs, Mathias and Balcar, Lorenz and Schleicher, Eva M and Söhngen, Jasmin and Müller, Lukas and Pitton, Michael B and Weinmann-Menke, Julia and Lange, Christian M and Galle, Peter R and Trauner, Michael and Mandorfer, Mattias and Reiberger, Thomas and Labenz, Christian and Hartl, Lukas},
  title = {Post‐ TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70736}
}
Kostenlos starten →